Metagenomi Technologies, Llc (MGX)
$1.95
Market is closed - opens 7 PM, 15 Oct 2024
Performance
- $1.86$1.97$1.95
4.62%
Downside
Day's Volatility :5.34%
Upside
0.76%
- $1.85$12.74$1.95
5.13%
Downside
52 Weeks Volatility :85.48%
Upside
84.69%
Returns
| Period | Metagenomi Technologies, Llc | Index (Russel 2000) |
|---|---|---|
3 Months | -60.24% | 0.0% |
6 Months | -77.05% | 0.0% |
1 Year | -80.99% | 0.0% |
3 Years | -80.99% | -22.2% |
Highlights
Market Capitalization | 101.1M |
Book Value | $7.19 |
Earnings Per Share (EPS) | -2.0 |
Wall Street Target Price | 17.0 |
Profit Margin | -134.1% |
Operating Margin TTM | -84.28% |
Return On Assets TTM | -13.92% |
Return On Equity TTM | -28.98% |
Revenue TTM | 55.9M |
Revenue Per Share TTM | 3.76 |
Quarterly Revenue Growth YOY | 76.5% |
Gross Profit TTM | 0.0 |
EBITDA | -83.5M |
Diluted Eps TTM | -2.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Buy
90%Buy
10%Hold
0
0%Sell
Based on 10 Wall street analysts offering stock ratings for Metagenomi Technologies, Llc(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 771.79%
Current $1.95
Target $17.00
Technicals Summary
Sell
Neutral
Buy
Metagenomi Technologies, Llc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Metagenomi Technologies, Llc | -28.47% | -77.05% | -80.99% | -80.99% | -80.99% |
 Regeneron Pharmaceuticals, Inc. | -11.92% | 13.03% | 20.39% | 82.8% | 232.53% |
 Novo Nordisk A/s | -12.32% | -3.12% | 18.68% | 139.03% | 361.43% |
 Alnylam Pharmaceuticals, Inc. | 5.16% | 92.5% | 70.0% | 35.85% | 259.26% |
 Vertex Pharmaceuticals Incorporated | -1.58% | 21.23% | 28.8% | 164.82% | 177.5% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Metagenomi Technologies, Llc | NA | NA | NA | 0.0 | -0.29 | -0.14 | NA | 7.19 |
Regeneron Pharmaceuticals, Inc. | 26.88 | 26.88 | 1.38 | 45.01 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 40.83 | 40.83 | 1.8 | 3.37 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.38 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.58 | 0.33 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Metagenomi Technologies, Llc | Buy | $101.1M | -80.99% | NA | -134.1% |
Regeneron Pharmaceuticals, Inc. | Buy | $110.1B | 232.53% | 26.88 | 32.04% |
Novo Nordisk A/s | Buy | $523.9B | 361.43% | 40.83 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $36.5B | 259.26% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $124.3B | 177.5% | 32.84 | -4.74% |
Company Information
Organization | Metagenomi Technologies, Llc |
Employees | 228 |
CEO | Dr. Brian Charles Thomas Ph.D. |
Industry | Miscellaneous |
Discover More
Metal Sky Star Acquisition Corp
$1.95
-0.51%
Stone Ridge 2054 Longevity Income Etf
$1.95
-0.51%
Nabors Energy Transition Corp Ii
$1.95
-0.51%
Dimensional Us Core Equity 1 Etf
$1.95
-0.51%
Natuzzi Spa
$1.95
-0.51%
Swan Hedged Equity Us Lg Cap
$1.95
-0.51%
Jpmorgan Activebuilders Emer
$1.95
-0.51%
Blackrock Income Trust Inc
$1.95
-0.51%
Roundhill Ball Metaverse Etf
$1.95
-0.51%